(Q73165992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Treatment of monomorphic B-cell lymphoma with rituximab after liver transplantation in a child (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

Amelia Caridad Sanchez Galindo

1 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Carmen Ramil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ivan Somoza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Alfonso Solar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Francisco Arnal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Augusto Alvarez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Pilar Sánchez-Mozo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Manuel Gómez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Transplantation

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

153-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

Epstein-Barr virus infections in children after transplantation of the small intestine

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid o

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00024.X

7 January 2021

10.1034/J.1399-3046.2003.00024.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12654058%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference